BMO Capital lowered the firm’s price target on GE Vernova (GEV) to $420 from $471 but keeps an Outperform rating on the shares after meeting with its management. The messaging following DeepSeek ...
Leerink analyst Roanna Ruiz lowered the firm’s price target on United Therapeutics (UTHR) to $420 from $430 and keeps an Outperform rating on the shares. United Therapeutics’ Q4 earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
